Autism through midlife: trajectories of symptoms, behavioral functioning, and health.

Accelerated longitudinal design Autism in adulthood Developmental trajectories Functioning Health Midlife and aging Symptoms

Journal

Journal of neurodevelopmental disorders
ISSN: 1866-1955
Titre abrégé: J Neurodev Disord
Pays: England
ID NLM: 101483832

Informations de publication

Date de publication:
03 Nov 2023
Historique:
received: 27 12 2022
accepted: 17 10 2023
medline: 6 11 2023
pubmed: 3 11 2023
entrez: 3 11 2023
Statut: epublish

Résumé

This study describes change in autism symptoms, behavioral functioning, and health measured prospectively over 22 years. Most studies tracking developmental trajectories have focused on autism during childhood, although adulthood is the longest stage of the life course. A robust understanding of how autistic people change through midlife and into older age has yet to be obtained. Using an accelerated longitudinal design with 9 waves of data, developmental trajectories were estimated from adolescence through midlife and into early old age in a community-based cohort (n = 406). The overall aim was to determine whether there were age-related increases or decreases, whether the change was linear or curvilinear, and whether these trajectories differed between those who have ID and those who have average or above-average intellectual functioning. Subsequently, the slopes of the trajectories were evaluated to determine if they differed depending on age when the study began, with the goal of identifying possible cohort effects. There were significant trajectories of age-related change for all but one of the measures, although different measures manifested different patterns. Most autism symptoms improved through adulthood, while health worsened. An inverted U-shaped curve best described change for repetitive behavior symptoms, activities of daily living, maladaptive behaviors, and social interaction. For these measures, improved functioning was evident from adolescence until midlife. Then change leveled off, with worsening functioning from later midlife into early older age. Additionally, differences between autistic individuals with and without ID were evident. Although those who have ID had poorer levels of functioning, there were some indications that those without ID had accelerating challenges in their aging years that were not evident in those with ID - increases in medications for physical health problems and worsening repetitive behaviors. Meeting the needs of the increasingly large population of autistic adults in midlife and old age requires a nuanced understanding of life course trajectories across the long stretch of adulthood and across multiple domains. Given the heterogeneity of autism, it will be important not to generalize across sub-groups, for example those who are minimally verbal and those who have above-average intellectual functioning.

Sections du résumé

BACKGROUND BACKGROUND
This study describes change in autism symptoms, behavioral functioning, and health measured prospectively over 22 years. Most studies tracking developmental trajectories have focused on autism during childhood, although adulthood is the longest stage of the life course. A robust understanding of how autistic people change through midlife and into older age has yet to be obtained.
METHODS METHODS
Using an accelerated longitudinal design with 9 waves of data, developmental trajectories were estimated from adolescence through midlife and into early old age in a community-based cohort (n = 406). The overall aim was to determine whether there were age-related increases or decreases, whether the change was linear or curvilinear, and whether these trajectories differed between those who have ID and those who have average or above-average intellectual functioning. Subsequently, the slopes of the trajectories were evaluated to determine if they differed depending on age when the study began, with the goal of identifying possible cohort effects.
RESULTS RESULTS
There were significant trajectories of age-related change for all but one of the measures, although different measures manifested different patterns. Most autism symptoms improved through adulthood, while health worsened. An inverted U-shaped curve best described change for repetitive behavior symptoms, activities of daily living, maladaptive behaviors, and social interaction. For these measures, improved functioning was evident from adolescence until midlife. Then change leveled off, with worsening functioning from later midlife into early older age. Additionally, differences between autistic individuals with and without ID were evident. Although those who have ID had poorer levels of functioning, there were some indications that those without ID had accelerating challenges in their aging years that were not evident in those with ID - increases in medications for physical health problems and worsening repetitive behaviors.
CONCLUSIONS CONCLUSIONS
Meeting the needs of the increasingly large population of autistic adults in midlife and old age requires a nuanced understanding of life course trajectories across the long stretch of adulthood and across multiple domains. Given the heterogeneity of autism, it will be important not to generalize across sub-groups, for example those who are minimally verbal and those who have above-average intellectual functioning.

Identifiants

pubmed: 37919643
doi: 10.1186/s11689-023-09505-w
pii: 10.1186/s11689-023-09505-w
pmc: PMC10623813
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

36

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH121438
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG08768
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD105353
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG008768
Pays : United States
Organisme : Autism Speaks
ID : #7724
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

J Autism Dev Disord. 2003 Dec;33(6):565-81
pubmed: 14714927
J Child Psychol Psychiatry. 2014 Jan;55(1):49-58
pubmed: 23848399
MMWR Surveill Summ. 2023 Mar 24;72(2):1-14
pubmed: 36952288
J Autism Dev Disord. 2009 Sep;39(9):1339-49
pubmed: 19434487
J Gerontol A Biol Sci Med Sci. 2014 Jun;69(6):640-9
pubmed: 24249734
Dev Psychol. 2014 Mar;50(3):699-708
pubmed: 24001150
J Autism Dev Disord. 2007 Oct;37(9):1735-47
pubmed: 17146700
Autism Res. 2019 Jun;12(6):911-921
pubmed: 31033222
Autism Res. 2018 Aug;11(8):1120-1128
pubmed: 29734508
Autism. 2022 Jan;26(1):243-255
pubmed: 34169776
Am J Public Health. 2017 May;107(5):791-793
pubmed: 28323463
Autism Res. 2021 Sep;14(9):1896-1904
pubmed: 34213066
Am Psychol. 2020 May-Jun;75(4):470-485
pubmed: 32378943
J Health Soc Behav. 1997 Mar;38(1):21-37
pubmed: 9097506
Int J Behav Dev. 2015 Jan 1;39(1):20-31
pubmed: 25580043
J Am Geriatr Soc. 2021 Mar;69(3):678-687
pubmed: 33155270
Autism. 2020 May;24(4):1011-1024
pubmed: 32191121
Arch Gen Psychiatry. 2005 Dec;62(12):1366-76
pubmed: 16330725
J Child Psychol Psychiatry. 2022 Sep;63(9):973-983
pubmed: 34890046
Arch Pediatr Adolesc Med. 2003 Jul;157(7):622-7
pubmed: 12860781
Autism. 2015 Oct;19(7):774-84
pubmed: 25922445
J Autism Dev Disord. 2015 Jan;45(1):111-26
pubmed: 25070471
J Autism Dev Disord. 2016 Jan;46(1):176-189
pubmed: 26319253
Autism. 2019 Oct;23(7):1732-1739
pubmed: 30818975
J Am Acad Child Adolesc Psychiatry. 2020 Dec;59(12):1342-1352
pubmed: 31863881
J Autism Dev Disord. 2014 Jun;44(6):1447-60
pubmed: 24287880
Neuroimage. 2021 Aug 1;236:118067
pubmed: 33878377
Autism Res. 2022 Apr;15(4):687-701
pubmed: 35084115
Lancet. 2022 Jan 15;399(10321):271-334
pubmed: 34883054
Nature. 2017 Feb 15;542(7641):348-351
pubmed: 28202961
Ann Behav Med. 2008 Dec;36(3):292-303
pubmed: 18937021
Psychol Aging. 2018 May;33(3):399-412
pubmed: 29756798
J Am Acad Child Adolesc Psychiatry. 2013 Jun;52(6):572-81.e1
pubmed: 23702446
Autism. 2015 Oct;19(7):794-804
pubmed: 25964655
Autism Adulthood. 2022 Jun 1;4(2):110-119
pubmed: 36605975
Autism. 2021 Feb;25(2):336-348
pubmed: 33143455
Autism Res. 2019 Jan;12(1):89-99
pubmed: 30101492
Am J Med Genet C Semin Med Genet. 2015 Jun;169(2):198-208
pubmed: 25959391
Am J Ment Retard. 2006 May;111(3):199-215
pubmed: 16597187
Mol Autism. 2019 Mar 1;10:9
pubmed: 30867896
J Am Acad Child Adolesc Psychiatry. 2021 Aug;60(8):978-985
pubmed: 33220430
Behav Brain Res. 2013 Nov 1;256:441-50
pubmed: 24004846
Disabil Health J. 2013 Jan;6(1):8-17
pubmed: 23260606
Psychopathology. 2001 Jul-Aug;34(4):187-91
pubmed: 11549928
J Autism Dev Disord. 2010 Dec;40(12):1431-46
pubmed: 20361245
Br J Psychiatry. 2016 Mar;208(3):232-8
pubmed: 26541693
Stat Methods Med Res. 2017 Feb;26(1):374-398
pubmed: 25147228
J Autism Dev Disord. 2016 Apr;46(4):1368-78
pubmed: 26707626
J Am Acad Child Adolesc Psychiatry. 2016 Mar;55(3):179-87
pubmed: 26903251
J Autism Dev Disord. 1994 Oct;24(5):659-85
pubmed: 7814313
Autism. 2015 Oct;19(7):814-23
pubmed: 25911091
J Am Acad Child Adolesc Psychiatry. 2012 Jun;51(6):622-31
pubmed: 22632621
J Autism Dev Disord. 2009 Jan;39(1):57-66
pubmed: 18566881
J Fam Issues. 2011 Mar 8;32(9):1178-1204
pubmed: 22180694
J Am Acad Child Adolesc Psychiatry. 2015 May;54(5):369-76.e3
pubmed: 25901773
J Child Psychol Psychiatry. 2020 Jul;61(7):760-767
pubmed: 31957035
J Autism Dev Disord. 2011 May;41(5):566-74
pubmed: 20640591

Auteurs

Jinkuk Hong (J)

Waisman Center, University of Wisconsin-Madison, 1500 Highland Ave, Madison, WI, 53705, USA. jhong4@wisc.edu.

Leann Smith DaWalt (LS)

Waisman Center, University of Wisconsin-Madison, 1500 Highland Ave, Madison, WI, 53705, USA.

Julie Lounds Taylor (JL)

Vanderbilt University Medical Center, 1211 Medical Center Drive, Nashville, TN, 37232, USA.

Aasma Haider (A)

Lawrence University, 711 E. Boldt Way, Appleton, WI, 54911, USA.

Marsha Mailick (M)

Waisman Center, University of Wisconsin-Madison, 1500 Highland Ave, Madison, WI, 53705, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH